Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Consulting agrmnt
Director departure
|
|
CHEMBIO DIAGNOSTICS, INC. (CEMI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
4
| Acheson David (Director) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Unknown transaction of 9,785 shares
@ $0.45, valued at
$4.4k
Exercised 4,892 restricted stock units
@ $0
Exercised 4,893 restricted stock units
@ $0
Disposed/sold 36,483 restricted stock units
@ $0
Disposed/sold 23,781 options to buy
@ $5.45, valued at
$129.6k
Disposed/sold 41,143 options to buy
@ $1.25, valued at
$51.4k
|
|
| 05/01/2023 |
4
| EBERLY RICHARD (See Remarks) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Paid exercise price by delivering 41,442 shares
@ $0.7, valued at
$29k
Paid exercise price by delivering 51,912 shares
@ $0.44, valued at
$22.8k
Paid exercise price by delivering 13,958 shares
@ $0.39, valued at
$5.4k
Paid exercise price by delivering 28,074 shares
@ $0.33, valued at
$9.3k
Unknown transaction of 241,759 shares
@ $0.45, valued at
$108.8k
Unknown transaction of 51,413 shares
@ $0.45, valued at
$23.1k
Exercised 38,709 restricted stock units
@ $0
Exercised 77,863 restricted stock units
@ $0
Exercised 144,000 restricted stock units
@ $0
Exercised 38,710 restricted stock units
@ $0
Exercised 77,863 restricted stock units
@ $0 |
|
| 05/01/2023 |
4
| Steenvoorden Lawrence J. (See remarks) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Disposed/sold 107,143 restricted stock units
@ $0
Disposed/sold 300,000 options to buy
@ $1.12, valued at
$336k
Paid exercise price by delivering 16,118 shares
@ $0.25, valued at
$4k
Unknown transaction of 37,453 shares
@ $0.45, valued at
$16.9k
Exercised 53,571 restricted stock units
@ $0 |
|
| 05/01/2023 |
4
| Bespalko David William (Director) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Unknown transaction of 11,469 shares
@ $0.45, valued at
$5.2k
Exercised 5,734 restricted stock units
@ $0
Exercised 5,735 restricted stock units
@ $0
Disposed/sold 37,735 restricted stock units
@ $0
Disposed/sold 31,746 options to buy
@ $4.65, valued at
$147.6k
Disposed/sold 41,143 options to buy
@ $1.25, valued at
$51.4k
|
|
| 05/01/2023 |
4
| Potthoff John Gary (Director) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Unknown transaction of 54,086 shares
@ $0.45, valued at
$24.3k
Exercised 16,314 restricted stock units
@ $0
Disposed/sold 32,000 restricted stock units
@ $0
Disposed/sold 46,875 options to buy
@ $8.15, valued at
$382k
Disposed/sold 36,252 options to buy
@ $2.36, valued at
$85.6k
Disposed/sold 41,143 options to buy
@ $1.25, valued at
$51.4k
|
|
| 05/01/2023 |
4
| Esfandiari Javan (See Remarks) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Paid exercise price by delivering 4,940 shares
@ $2.38, valued at
$11.8k
Paid exercise price by delivering 16,950 shares
@ $0.44, valued at
$7.5k
Paid exercise price by delivering 4,652 shares
@ $0.39, valued at
$1.8k
Unknown transaction of 145,612 shares
@ $0.45, valued at
$65.5k
Exercised 12,903 restricted stock units
@ $0
Exercised 48,000 restricted stock units
@ $0
Exercised 12,903 restricted stock units
@ $0
Disposed/sold 108,904 restricted stock units
@ $0
Disposed/sold 188,064 options to buy
@ $2.36, valued at
$443.8k
Disposed/sold 107,143 options to buy
@ $4.65, valued at
$498.2k
Disposed/sold 277,714 options to buy
@ $1.25, valued at
$347.1k
|
|
| 05/01/2023 |
4
| Teso-Lichtman Leslie (Director) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Disposed/sold 96,000 restricted stock units
@ $0
Disposed/sold 41,143 options to buy
@ $1.25, valued at
$51.4k
Disposed/sold 82,286 options to buy
@ $1.25, valued at
$102.9k
|
|
| 05/01/2023 |
4
| Caso Charles (See Remarks) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Paid exercise price by delivering 1,444 shares
@ $0.77, valued at
$1.1k
Paid exercise price by delivering 10,311 shares
@ $0.44, valued at
$4.5k
Paid exercise price by delivering 2,775 shares
@ $0.39, valued at
$1.1k
Unknown transaction of 34,674 shares
@ $0.45, valued at
$15.6k
Exercised 4,101 restricted stock units
@ $0
Exercised 29,333 restricted stock units
@ $0
Exercised 7,885 restricted stock units
@ $0
Disposed/sold 70,655 restricted stock units
@ $0
Disposed/sold 65,476 options to buy
@ $4.65, valued at
$304.5k
Disposed/sold 169,714 options to buy
@ $1.25, valued at
$212.1k
|
|
| 05/01/2023 |
4
| Davis Katherine Lyon (Director) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Unknown transaction of 106,457 shares
@ $0.45, valued at
$47.9k
Exercised 16,314 restricted stock units
@ $0
Disposed/sold 32,000 restricted stock units
@ $0
Disposed/sold 36,252 options to buy
@ $2.36, valued at
$85.6k
Disposed/sold 41,143 options to buy
@ $1.25, valued at
$51.4k
|
|
| 05/01/2023 |
4
| Perceptive Credit Advisors, LLC (Former 10% Owner) has filed a Form 4 on CHEMBIO DIAGNOSTICS, INC.|
Txns:
| Unknown transaction of 5,162,782 shares
@ $0.45, valued at
$2.3M
|
|
| 05/01/2023 |
SC 13D
| Biosynex SA reports a 100% stake in Chembio Diagnostics, Inc. |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/27/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/27/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/27/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
|
|
|